Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Last time updated on 28/11/2020